Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Infant formula-National Institute of Allergy and Infectious Diseases (NIAID) refers to an investigational high-calorie nutritional intervention studied in the clinical trial NCT00000873. This intervention compared an increased caloric density formula (approximately 26 kcal/oz or 87 kcal/100 ml) against a standard commercial infant formula (20 kcal/oz or 67 kcal/100 ml). Developed by the NIAID, the study targeted HIV-exposed and HIV-infected infants during their first six months of life to evaluate the impact of early caloric supplementation on growth, nutritional status, immune function, and disease progression. The intervention aimed to mitigate the growth failure and nutritional deficiencies frequently observed in pediatric HIV cases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on infant formula-National Institute of Allergy and Infectious Diseases (NIAID).